Matthew C. Kiernan

44.5k total citations · 3 hit papers
672 papers, 28.4k citations indexed

About

Matthew C. Kiernan is a scholar working on Neurology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew C. Kiernan has authored 672 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 413 papers in Neurology, 163 papers in Genetics and 127 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew C. Kiernan's work include Amyotrophic Lateral Sclerosis Research (291 papers), Neurogenetic and Muscular Disorders Research (148 papers) and Parkinson's Disease Mechanisms and Treatments (122 papers). Matthew C. Kiernan is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (291 papers), Neurogenetic and Muscular Disorders Research (148 papers) and Parkinson's Disease Mechanisms and Treatments (122 papers). Matthew C. Kiernan collaborates with scholars based in Australia, United Kingdom and United States. Matthew C. Kiernan's co-authors include Steve Vucic, Arun V. Krishnan, Cindy Lin, Orla Hardiman, Martin R. Turner, Susanna B. Park, David Burke, Benjamin C. Cheah, James R. Burrell and Parvathi Menon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Matthew C. Kiernan

640 papers receiving 27.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyotrophic lateral sclerosis

2011 1.9k citations Matthew C. Kiernan, Steve Vucic et al. profile →
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

2013 558 citations Susanna B. Park, David Goldstein et al. profile →
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

2022 231 citations Orla Hardiman, Ammar Al‐Chalabi et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew C. Kiernan Australia	83	16.3k	7.4k	5.4k	5.1k	4.6k	672	28.4k
Michael Swash United Kingdom	75	11.9k 0.7×	5.5k 0.7×	3.1k 0.6×	2.7k 0.5×	4.4k 1.0×	484	26.6k
Pamela J. Shaw United Kingdom	89	16.6k 1.0×	8.9k 1.2×	5.2k 1.0×	9.8k 1.9×	5.1k 1.1×	486	29.4k
Eva L. Feldman United States	105	13.1k 0.8×	2.9k 0.4×	6.4k 1.2×	11.0k 2.2×	3.7k 0.8×	573	41.5k
Haruhiko Akiyama Japan	88	8.7k 0.5×	2.8k 0.4×	4.2k 0.8×	13.2k 2.6×	8.1k 1.8×	591	35.4k
Gary K. Steinberg United States	86	10.3k 0.6×	2.7k 0.4×	4.6k 0.9×	6.3k 1.2×	4.5k 1.0×	521	26.7k
Gen Sobue Japan	82	11.6k 0.7×	4.7k 0.6×	9.6k 1.8×	12.4k 2.4×	2.9k 0.6×	754	28.1k
Robert H. Brown United States	93	15.7k 1.0×	9.1k 1.2×	6.3k 1.2×	17.9k 3.5×	4.5k 1.0×	310	34.4k
Albert C. Ludolph Germany	77	15.0k 0.9×	6.2k 0.8×	4.8k 0.9×	7.1k 1.4×	3.8k 0.8×	669	25.0k
James R. Connor United States	86	5.3k 0.3×	3.6k 0.5×	2.1k 0.4×	5.7k 1.1×	3.7k 0.8×	386	24.5k
Mei Lü United States	80	3.3k 0.2×	6.4k 0.9×	3.5k 0.6×	7.0k 1.4×	4.7k 1.0×	377	24.3k

Countries citing papers authored by Matthew C. Kiernan

Since Specialization

Citations

This map shows the geographic impact of Matthew C. Kiernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Kiernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Kiernan more than expected).

Fields of papers citing papers by Matthew C. Kiernan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew C. Kiernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Kiernan. The network helps show where Matthew C. Kiernan may publish in the future.

Co-authorship network of co-authors of Matthew C. Kiernan

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew C. Kiernan. A scholar is included among the top collaborators of Matthew C. Kiernan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew C. Kiernan. Matthew C. Kiernan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trottier, Caitlin A., Meghan I. Short, Angie Mae Rodday, et al.. (2024). Impact of type of mechanical circulatory support before transplant on postorthotopic heart transplantation infections. The Journal of Heart and Lung Transplantation. 44(2). 215–224. 1 indexed citations

Eijk, Ruben P. A. van, Matthew C. Kiernan, Allan F. McRae, et al.. (2024). Amyotrophic lateral sclerosis established as a multistep process across phenotypes. European Journal of Neurology. 32(1). e16532–e16532. 2 indexed citations

Menon, Parvathi, Nathan Pavey, Aman S. Aberra, et al.. (2023). Dependence of cortical neuronal strength-duration properties on TMS pulse shape. Clinical Neurophysiology. 150. 106–118. 2 indexed citations

Pavey, Nathan, Parvathi Menon, Mehdi van den Bos, Matthew C. Kiernan, & Steve Vucic. (2023). Cortical inhibition and facilitation are mediated by distinct physiological processes. Neuroscience Letters. 803. 137191–137191. 6 indexed citations

Hannaford, Andrew, Karen Byth, Nathan Pavey, et al.. (2022). Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve. 67(1). 17–24. 4 indexed citations

Mizrahi, David, David Goldstein, Matthew C. Kiernan, et al.. (2022). Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer. 30(7). 5965–5974. 8 indexed citations

Gabery, Sanaz, Rebekah M. Ahmed, Jashelle Caga, et al.. (2021). Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. 47(7). 979–989. 38 indexed citations

Salmon, Kristiana, Matthew C. Kiernan, Seung Hyun Kim, et al.. (2021). The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis. Brain. 145(4). 1207–1210. 24 indexed citations

Higashihara, Mana, Mehdi van den Bos, Parvathi Menon, Matthew C. Kiernan, & Steve Vucic. (2020). Interneuronal networks mediate cortical inhibition and facilitation. Clinical Neurophysiology. 131(5). 1000–1010. 12 indexed citations

10.

Hironaka, Camille E., et al.. (2020). Untwist the twist: instant hemodynamic improvement in known HeartMate 3 complication. Journal of Artificial Organs. 24(3). 365–367. 2 indexed citations

11.

Kiernan, Matthew C.. (2019). Jewels in the crown: a century of achievement for theJournal of Neurology, Neurosurgery & Psychiatry. Journal of Neurology Neurosurgery & Psychiatry. 91(1). 1–2. 1 indexed citations

12.

Issar, Tushar, Ria Arnold, Natalie Kwai, et al.. (2018). The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study. Clinical Neurophysiology. 129(5). 889–894. 12 indexed citations

13.

Kiernan, Matthew C., John Calvin Coffey, Kieran W. McDermott, et al.. (2018). The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis. Journal of Crohn s and Colitis. 13(1). 58–66. 48 indexed citations

14.

Geevasinga, Nimeshan, Parvathi Menon, Daniel Scherman, et al.. (2016). Diagnostic criteria in amyotrophic lateral sclerosis. Neurology. 87(7). 684–690. 36 indexed citations

15.

Kiernan, Matthew C., Douglas Gregory, Patrick Rossignol, et al.. (2015). Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure. JACC Heart Failure. 3(3). 214–223. 16 indexed citations

16.

Colvin, Monica, Jennifer Cook, Patricia P. Chang, et al.. (2015). Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management. Circulation. 131(18). 1608–1639. 229 indexed citations

17.

Park, Susanna B., Cindy Lin, Arun V. Krishnan, et al.. (2014). Axonal dysfunction with voltage gated potassium channel complex antibodies. Experimental Neurology. 261. 337–342. 11 indexed citations

18.

Turner, Martin R., Orla Hardiman, Michael Benatar, et al.. (2013). Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology. 12(3). 310–322. 385 indexed citations

19.

Vucic, Steve, Benjamin C. Cheah, & Matthew C. Kiernan. (2011). Maladaptation of cortical circuits underlies fatigue and weakness in ALS. Amyotrophic Lateral Sclerosis. 12(6). 414–420. 21 indexed citations

20.

Park, Susanna B., Cindy Lin, David Burke, & Matthew C. Kiernan. (2011). Activity‐dependent conduction failure: molecular insights. Journal of the Peripheral Nervous System. 16(3). 159–168. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact